97307 ⎘
Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
CD3 epsilon immunogens and antibodies
#12002Antibody drug conjugates (ADC) that bind to 161P2F10B proteins
#12003Anti-platelet membrane glycoprotein VI monoclonal antibody
#12004Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
#12005Monoclonal antibodies directed to CD20
#12006Therapeutic DLL4 binding proteins
#12007Conformation specific antibodies
#12008Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
#12009Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#12010GLUCAGON RECEPTOR ANTAGONISTS
#12011MATERIALS AND METHODS FOR INHIBITING CANCER CELL INVASION
#12012Antibody Fc mutants with ablated effector functions
#12013BINDING MEMBERS FOR IGE MOLECULES
#12014Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
#12015Antibodies to lymphotoxin-α
#12016SAM-6 VARIANTS, TARGET AND METHODS OF USE
#12017Fuel Cell System and Method for Operation of a Fuel Cell System
#12018Methods and compositions for modulating hepatocyte growth factor activator
#12019Compositions and methods for the diagnosis and treatment of tumor
#12020Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
#12021Anti-IL-7 receptor antibodies
#12022IL-23 ANTIBODIES
#12023Binding molecules to the human OX40 receptor
#12024Antigen-Binding Molecule And Uses Thereof
#12025Anti-interferon-α antibodies
#12026Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
#12027COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#12028ANTIVIRAL AGENT AGAINST ANIMAL VIRUSES
#12029G immunoglobulin used against anthrax toxins
#12030MANNOSE 6-PHOSPHATE-BINDING ANTIBODIES AND THEIR USES
#12031Anti-CD147 antibodies, methods and uses
#12032Antibodies that neutralize botulinum neurotoxins
#12033Plasma kallikrein binding proteins
#12034Methods of using insulin-like growth factor antibodies to treat tumors
#12035CD127 binding proteins
#12036VHH ANTIBODY FRAGMENTS FOR USE IN THE DETECTION AND TREATMENT OF CANCER
#12037DLL4-BINGING MOLECULES
#12038Nucleic acids encoding human anti-IL-23 antibodies
#12039Common light chain mouse
#12040IMMUNIZATION PROTOCOL FOR DIRECTED EXPANSION AND MATURATION
#12041Method of using fusion proteins
#12042Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2
#12043CD20 antibodies and uses thereof
#12044CD20 antibodies and uses thereof
#12045Anti-hepcidin-25 selective antibodies and uses thereof
#12046Antibodies against candida, collections thereof and methods of use
#12047Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions
#12048RECOMBINANT ANTIBODIES FOR TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
#12049PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODIES AND ANTIGEN BINDING FRAGMENTS
#12050Dock-and-lock (DNL) vaccines for cancer therapy
#12051Human GM-CSF antigen binding proteins
#12052Biological products
#12053SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#12054METHODS TO STABILIZE PROTEINS AND POLYPEPTIDES
#12055SOMATIC HYPERMUTATION SYSTEMS
#12056Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same
#12057ANTIBODIES TO BONE MORPHOGENIC PROTEINS AND RECEPTORS THEREFOR AND METHODS FOR THEIR USE
#12058Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
#12059Antibody variants
#12060HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
#12061P-cadherin antibodies
#12062DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EFFECTS: APPLICATION TO ANTI-EGFR ANTIBODIES
#12063Antibody against the CSF-1R
#12064STABILIZED SINGLE DOMAIN ANTIBODIES
#12065Anti-HER2 antibodies and their uses
#12066P2X7 epitopes
#12067Compositions and methods for inhibiting PDGFRβ and VEGF-A
#12068BISPECIFIC BINDING MOLECULES FOR ANTI-ANGIOGENESIS THERAPY
#12069Anti-PSGL-1 antibodies
#12070Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
#12071ANTI-PlGF ANTIBODIES AND METHODS USING SAME
#12072Anti-HER3 antibodies and uses thereof
#12073Humanized monoclonal antibodies and methods of use
#12074Antibodies to NTB-A
#12075Anti-FcRH5 antibodies and immunoconjugates and methods of use
#12076IL-17 receptor A antigen binding proteins
#12077GPCR crystalization method using an antibody
#12078Biological products
#12079Co-crystal structure of factor D and anti-factor D antibody
#12080Nucleic acids encoding anti-factor D antibodies
#12081Methods for treating inflammatory conditions using antibodies that bind PAR-2
#12082OSTEOPONTIN ANTIBODIES
#12083NOVAL MADCAM ANTIBODIES
#12084Antibodies against human CSF-1R and uses thereof
#12085ANTI CD37 ANTIBODIES
#12086IGF-II/IGF-IIE BINDING PROTEINS
#12087Interleukin-13 binding proteins
#12088IL-1 BINDING PROTEINS
#12089Cab Molecules
#12090Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19
#12091ADENOVIRUS TARGETING
#12092Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies
#12093Human antibodies to human angiopoietin-like protein 4
#12094Anti-HER2 antibody variants
#12095Anti-ADDL antibodies and uses thereof
#12096Anti-VEGF antibodies
#12097Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
#12098Stable and soluble antibodies inhibiting TNFα
#12099Engineered Anti-IL-23R Antibodies
#12100Humanized antibodies that sequester amyloid beta peptide
#12101METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#12102ANTI-ORTHOPOXVIRUS RECOMBINANT POLYCLONAL ANTIBODY
#12103HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4
#12104FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS
#12105Antibody against PcrV
#12106Antibody specifically binding to angiopoietin-2 and use thereof
#12107ANTI-TRKB MONOCLONAL ANTIBODIES AND USES THEREOF
#12108HUMAN ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3) AND USES THEREOF
#12109Anti-hepcidin antibodies and methods of use
#12110Fully human anti-human NKG2D monoclonal antibodies
#12111Antibodies to lymphotoxin-α
#12112PRLR-specific antibody and uses thereof
#12113Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
#12114Antibodies and derivatives thereof
#12115Interleukin 10 receptor, (IL-10R) antibodies
#12116ANTI-VEGF-C ANTIBODIES AND METHODS USING SAME
#12117Antibodies and immunoconjugates and uses therefor
#12118Multispecific antibodies
#12119PCSK9 antagonists
#12120NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF
#12121Antibodies against amyloid-β peptide
#12122IL-1 binding proteins
#12123Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#12124Compositions and methods for the diagnosis and treatment of tumor
#12125Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#12126Anti-CD79B antibodies and immunoconjugates and methods of use
#12127Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein
#12128Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereof
#12129HUMAN ANTIBODIES NEUTRALIZING HUMAN METAPNEUMOVIRUS
#12130Recombinant anti-epidermal growth factor receptor antibody compositions
#12131Anti-alpha2 integrin antibodies and their uses
#12132Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
#12133METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINS
#12134Ganglioside epitopes for treating guillain-barre syndrome
#12135METHODS FOR SYSTEMATIC CONTROL OF PROTEIN STABILITY
#12136Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions
#12137VNAR anti-cytokine domains
#12138ANTI-NR10 ANTIBODY AND USE THEREOF
#12139Variant Hhip1 protein and methods and uses thereof
#12140Antibodies Directed to CD20 and Uses Thereof
#12141Peptide that binds to a broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex, uses thereof, compositions therefrom
#12142Generation and affinity maturation of antibody library in silico
#12143Antibodies to EphA3
#12144HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING
#12145Human monoclonal nicotine specific antibodies
#12146Methods of treating with anti-factor D antibodies
#12147Antibodies against ERBB3 and uses thereof
#12148Altered Antibody FC Regions and Uses Thereof
#12149Dock-and-lock (DNL) complexes for delivery of interference RNA
#12150METHODS AND MATERIALS FOR TARGETED AFFINITY ENHANCEMENT
#12151AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION
#12152Methods and materials for targeted mutagenesis
#12153Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
#12154IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM
#12155Anti-EGFR antibodies and their uses
#12156Humanization of rabbit antibodies using a universal antibody framework
#12157Monoclonal antibodies to progastrin and their uses
#12158Therapeutic DLL4 binding proteins
#12159Methods of treating an inflammatory condition involving VAP-1-mediated adhesion with VAP-1-specific antibodies
#12160ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
#12161Heparin-binding epidermal growth factor-like growth factor binding proteins
#12162ANTI-ALK1 ANTIBODIES AND USES THEREOF
#12163Anti-GCC antibody molecules and related compositions and methods
#12164Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS
#12165Multivalent immunoglobulin-based bioactive assemblies
#12166NOVEL COMPOUNDS
#12167Human anti-B7RP1 neutralizing antibodies
#12168Antibody fragment-polymer conjugates and uses of same
#12169Antibody specifically binding to c-Met
#12170Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
#12171Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof
#12172Antibodies against CD38 for treatment of multiple myeloma
#12173Antibody molecules that bind to IL-6 receptor
#12174Antibody modulators of hepatocyte growth factor activator
#12175Polynucleotide encoding a sclerostin-binding antibody
#12176Treatment of chronic prostatitis
#12177Fully human anti-VEGF antibodies and methods of using
#12178Anti-TrkB antibodies
#12179HER2/neu-specific antibodies and methods of using same
#12180COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCER
#12181Methods of affinity maturing antibodies
#12182CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT
#12183Antigen-Binding Proteins Targeting S. Aureus Orf0657n
#12184Methods of using antibodies against human IL-22
#12185Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors
#12186ANTI-FLT3 ANTIBODIES
#12187Connective tissue growth factor antibodies
#12188Method of using anti-IL-13 antibodies
#12189Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation
#12190Single domain antibodies capable of modulating BACE activity
#12191Dual variable domain immunoglobulins and uses thereof
#12192Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
#12193Anti-FGF19 antibodies and methods using same
#12194Anti-CXCR4 antibodies
#12195POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR
#12196Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#12197Nucleic acids encoding anti-IL-12 antibody
#12198Nucleic acid molecules which encode human anti-CD20 antibodies and methods of use thereof
#12199Methods of treating conditions using anti-IL-6 antibodies
#12200Anti-CTLA-4 antibodies with reduced blocking of binding of CTLA-4 to B7 and uses thereof
#12201ANTI-VEGF ANTIBODIES
#12202Methods of using IL-17 receptor a antibodies
#12203HINGE DOMAIN ENGINEERING
#12204ANTIBODY-PEPTIDE FUSED SYNERGIBODY
#12205Modulators
#12206FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING
#12207Therapeutic Binding Molecules
#12208Humanized antibody compositions and methods for binding lysophosphatidic acid
#12209Endoglin antibodies
#12210Humanized anti-FGF19 antagonists and methods using same
#12211SPECIFIC BINDING PROTEINS AND USES THEREOF
#12212RESISTIN ANTAGONISTS AND THEIR USE
#12213Compositions and methods relating to anti-IGF-1 receptor antibodies
#12214COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC
#12215Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
#12216Compositions and methods for the therapy and diagnosis of influenza
#12217High affinity human antibodies to PCSK9
#12218Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
#12219Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
#12220Extracellular targeted drug conjugates
#12221Targeted immunoconjugates
#12222PREVENTION AND TREATMENT OF PAIN USING ANTIBODIES TO LYSOPHOSPHATIDIC ACID
#12223HUMAN ANTI-CANCER ANTIBODIES
#12224CA6 antigen-specific cytotoxic conjugate and methods of using the same
#12225Immunoglobulin Variants Outside the Fc Region
#12226ANTI IgE ANTIBODIES
#12227Class I anti-CEA antibodies and uses thereof
#12228ANTI-ROBO4 ANTIBODIES AND USES THEREFOR
#12229Methods for inducing or enhancing an immune response by administering agonistic GITR-binding antibodies
#12230Antikine antibodies that bind to multiple CC chemokines
#12231Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
#12232Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof
#12233Use of an anti-Tau pS422 antibody for the treatment of brain diseases
#12234Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
#12235IL-23 antagonists
#12236Method for treating psoriasis
#12237Method for treating psoriasis
#12238Agent for treating disease
#12239Humanized anti-human α9-integrin antibody
#12240ANTI-ROBO4 ANTIBODIES AND USES THEREFOR
#12241Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
#12242Methods of treating inflammatory pain
#12243Humanized anti-human NKG2A monoclonal antibody
#12244Anti-IL-13Rα1 antibodies and their uses thereof
#12245Antibodies to IL-17A
#12246Compositions and methods for use for antibodies against sclerostin
#12247Humanized anti-CDCP1 antibodies
#12248ANTI-VEGF ANTIBODIES
#12249Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
#12250Anti-CD19 antibodies
#12251Cytotoxic immunoglobulin
#12252Humanized high affinity recombinant antibody against Hepatitis B surface antigen
#12253Anti-GM-CSF antibodies
#12254Stabilized angiopoietin-2 antibodies and uses thereof
#12255NEUTRALIZING ANTIBODIES
#12256ANTIBODY DESIGN USING ANTI-LIPID ANTIBODY CRYSTAL STRUCTURES
#12257Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
#12258Anti-amyloid antibodies and uses thereof
#12259Antibodies directed against amyloid-beta peptide and methods using same
#12260Dual Variable Domain Immunoglobulins and Uses Thereof
#12261Humanized antibodies
#12262Human anti-IL-23 antibodies, compositions, methods and uses
#12263Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
#12264LIBRARIES, ARRAYS AND THEIR USES FOR TARGETED AFFINITY ENHANCEMENT
#12265Tag peptide and use thereof
#12266ANTIBODIES AGAINST INFLUENZA VIRUS AND METHODS OF USE THEREOF
#12267Antibodies to IL-17A
#12268Monoclonal antibodies against CD32B
#12269Methods of Treating Alzheimer's Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions Thereof
#12270Methods for the treatment of IL-1β related diseases
#12271Treatment and prophylaxis of amyloidosis
#12272ANTI-SIALIC ACID ANTIBODY MOLECULES
#12273COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA
#12274Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use
#12275ANTI-ErbB2 ANTIBODIES
#12276Antibody against anthrax toxins
#12277Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
#12278Cysteine Engineered Antibodies For Site-Specific Conjugation
#12279Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof
#12280Anti-IL-17 antibodies
#12281ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
#12282High affinity human antibodies to human angiopoietin-2
#12283Nogo-A binding molecules and pharmaceutical use thereof
#12284SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#12285Anti-mesothelin antibodies and uses thereof
#12286Humanized anti-CXCR5 antibodies, derivatives thereof and their use
#12287Anti-hepcidin antibodies and uses thereof
#12288Hybrid antibodies
#12289Optimized Fc Variants
#12290Engineered anti-TSLPR antibodies
#12291Targeted binding agents directed to PDGRF-alpha and uses thereof
#12292Anti-factor XI monoclonal antibodies and methods of use thereof
#12293Anti-VEGF antibodies
#12294Human monoclonal antibodies specific for CD22
#12295METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION
#12296Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
#12297Human anti-α9 integrin antibody
#12298Composition for neutralizing botulinus toxin type-A, and human anti-botulinus toxin type-A antibody
#12299IL-18 receptor antigen binding proteins
#12300Anti-IL 13 antibodies and uses thereof